Antibody-mediated immunotherapy against chronic hepatitis B virus infection
The currently available drugs to treat hepatitis B virus (HBV) infection include interferons and nucleos(t)ide analogs, which can only induce disease remission and are inefficient for the functional cure of patients with chronic HBV infection (CHB). Since high titers of circulating hepatitis B surfa...
Saved in:
Main Authors: | Ying Gao (Author), Tian-Ying Zhang (Author), Quan Yuan (Author), Ning-Shao Xia (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dendritic cell‐based immunotherapy: A potential therapeutic option for chronic Hepatitis B virus infection
by: Xuejie Wu, et al.
Published: (2023) -
Clinical and virological characteristics of coexistent hepatitis B surface antigen and antibody in treatment-naive children with chronic hepatitis B virus infection
by: Yi Xu, et al.
Published: (2024) -
A Practical Approach to Immunotherapy of Hepatocellular Carcinoma Using T Cells Redirected Against Hepatitis B Virus
by: Sarene Koh, et al.
Published: (2013) -
Antibody immunoprophylaxis and immunotherapy for influenza virus infection: Utilization of monoclonal or polyclonal antibodies?
by: Cassandra M. Berry
Published: (2018) -
Entecavir Treatment in Children and Adolescents with Chronic Hepatitis B Virus Infection
by: Kai-Chi Chang, et al.
Published: (2016)